INTELLIGENCE IN ACTION

PRICE TRANSPARENCY

Prescription price transparency is critical to lowering patients’ out-of-pocket costs and preventing “sticker shock” at the pharmacy, which negatively impacts medication adherence and patient safety.

Recent Articles

PRICE TRANSPARENCY

March 15, 2019

HIMSS19 Highlights: Five Takeaways from Healthcare Leaders on Prescription Price Transparency

By Kate Rusciano

4minutes

PRICE TRANSPARENCY

February 19, 2019

Disrupting the Drug Cost Trajectory: Dr. Michelle Mello on Making Medications Affordable

By Melissa Nix

12minutes

PRICE TRANSPARENCY

February 13, 2019

Prescribers and Patients are Working Together to Save Time, Money and Hassle

By Tom Skelton

4minutes

PRICE TRANSPARENCY

December 18, 2018

Federal Government Takes Action to Spur Greater Use of Prescription Price Transparency Tools at the Point of Care

By Mary Ann Chafee, Vice President of Policy and Federal Affairs, Surescripts

3minutes

PRICE TRANSPARENCY

December 03, 2018

How Prescribers are Saving Their Patients Thousands of Dollars on Drugs

By Ryan Hess

3minutes

PRICE TRANSPARENCY

November 14, 2018

Reinventing the Health IT Adoption Curve: Price Transparency at the Point of Care

By Jacqueline Hager, Product Manager, Surescripts

2minutes

PRICE TRANSPARENCY

September 17, 2018

Actionable Intelligence at the Point of Care can Help Prevent Physician Burnout

By Ryan Hess

9minutes

PRICE TRANSPARENCY

September 07, 2018

Surescripts Tackles Prescription Abandonment with Point-of-Care Information That Supports Patient-Provider Shared Decision Making

By Guest Contributor Nancy Fabozzi, Principal Analyst for Digital Health

6minutes

PRICE TRANSPARENCY

August 28, 2018

Five Questions: Mary Ann Chaffee on Price Transparency, Public Health and the Notorious R.B.G.

By Melissa Nix, Editorial Director, Marketing

7minutes

PRICE TRANSPARENCY

August 01, 2018

Patients, Pocketbooks and a Podcast on Prescription Price Transparency

By Melissa Nix, Editorial Director, Marketing

2minutes

PRICE TRANSPARENCY

April 23, 2018

Patients’ Out-of-Pocket Cost Should Weigh Into Prescribing Decisions

By Ryan Hess

5minutes

PRICE TRANSPARENCY

March 22, 2018

HIMSS18 Panel Gets Candid About Prescription Price Transparency

By Kelly Jeffers, Marketing, Surescripts

3minutes

Load more articles

INTELLIGENCE IN ACTION

PRICE TRANSPARENCY

Recent Articles

HIMSS19 Highlights: Five Takeaways from Healthcare Leaders on Prescription Price Transparency

Disrupting the Drug Cost Trajectory: Dr. Michelle Mello on Making Medications Affordable

Prescribers and Patients are Working Together to Save Time, Money and Hassle

Federal Government Takes Action to Spur Greater Use of Prescription Price Transparency Tools at the Point of Care

How Prescribers are Saving Their Patients Thousands of Dollars on Drugs

Reinventing the Health IT Adoption Curve: Price Transparency at the Point of Care

Actionable Intelligence at the Point of Care can Help Prevent Physician Burnout

Surescripts Tackles Prescription Abandonment with Point-of-Care Information That Supports Patient-Provider Shared Decision Making

Five Questions: Mary Ann Chaffee on Price Transparency, Public Health and the Notorious R.B.G.

Patients, Pocketbooks and a Podcast on Prescription Price Transparency

Patients’ Out-of-Pocket Cost Should Weigh Into Prescribing Decisions

HIMSS18 Panel Gets Candid About Prescription Price Transparency

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX